10.15.24
North Carolina’s Healthy Opportunities Pilots (HOP) is the nation’s first comprehensive program aimed at addressing non-medical, health-related needs for qualifying Medicaid enrollees. Melinda Dutton, a partner at Manatt Health recently facilitated a fireside chat with North ...
10.10.24
As we approach election day 2024, Manatt is committed to keeping you informed about the potential new health care policies in a new administration and how those polices will impact you and the American public.
On October 4, the Centers for Medicare & Medicaid Services (CMS) released the proposed Notice of Benefit and Payment Parameters (NBPP) for plan year 2026.
On October 2, the Centers for Medicare & Medicaid Services (CMS) released final guidance outlining how the agency will implement the Inflation Reduction Act’s (IRA) Medicare Drug Price Negotiation Program (the “Program”) for initial price applicability year (IPAY) 2027, the ...
On September 26, the Centers for Medicare and Medicaid Services (CMS) released comprehensive guidance to states that reinforces and clarifies federal Medicaid requirements regarding Early and Periodic Screening, Diagnostics, and Treatment (EPSDT).
10.08.24
This study analyzed the Texas OB/GYN physician workforce and the impact of the state’s abortion laws on the workforce development pipeline.
10.03.24
On September 20, the Centers for Medicare & Medicaid Services (CMS) issued guidance detailing the timeline and expectations for states to fully comply with federal Medicaid and Children’s Health Insurance Program (CHIP) renewal requirements.
On September 24, the HHS Office of Inspector General (OIG) released a report calling for “additional oversight of remote patient monitoring in Medicare.”
10.01.24
North Carolina is transforming its behavioral health system by expanding Medicaid and access to care. This transformation builds upon the years of foundational efforts by the Cooper administration to invest in the behavioral health continuum and workforce and expand integrated physical and ...
09.26.24
On Wednesday, September 18, Washington’s Prescription Drug Affordability Board (PDAB) finalized its methodology for selecting drugs for affordability reviews.